Your browser doesn't support javascript.
loading
Epidemiology of Invasive Candidiasis.
Bays, Derek J; Jenkins, Emily N; Lyman, Meghan; Chiller, Tom; Strong, Nora; Ostrosky-Zeichner, Luis; Hoenigl, Martin; Pappas, Peter G; Thompson Iii, George R.
Afiliação
  • Bays DJ; Department of Internal Medicine, Division of Infectious Diseases, School of Medicine, University of California Davis, Sacramento, CA, USA.
  • Jenkins EN; ASRT, Inc, Atlanta, GA, USA.
  • Lyman M; Mycotic Disease Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Chiller T; Mycotic Disease Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Strong N; Mycotic Disease Branch, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ostrosky-Zeichner L; Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Hoenigl M; Division of Infectious Diseases, Department of Internal Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  • Pappas PG; Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria.
  • Thompson Iii GR; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, La Jolla, CA, USA.
Clin Epidemiol ; 16: 549-566, 2024.
Article em En | MEDLINE | ID: mdl-39219747
ABSTRACT
Invasive candidiasis (IC) is an increasingly prevalent, costly, and potentially fatal infection brought on by the opportunistic yeast, Candida. Previously, IC has predominantly been caused by C. albicans which is often drug susceptible. There has been a global trend towards decreasing rates of infection secondary to C. albicans and a rise in non-albicans species with a corresponding increase in drug resistance creating treatment challenges. With advances in management of malignancies, there has also been an increase in the population at risk from IC along with a corresponding increase in incidence of breakthrough IC infections. Additionally, the emergence of C. auris creates many challenges in management and prevention due to drug resistance and the organism's ability to transmit rapidly in the healthcare setting. While the development of novel antifungals is encouraging for future management, understanding the changing epidemiology of IC is a vital step in future management and prevention.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Epidemiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Clin Epidemiol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos